2024
INTEGRATED PHENOTYPIC AND ACTIVITY-BASED PROFILING OF ELECTROPHILIC FRAGMENTS REVEALS NEW TARGETS FOR ANTIBIOTICS DEVELOPMENT
Jin, Y., Jana, S., Abbasov, M. E.,* Lin, H.*
BioRvix 2024 DOI: 10.1101/2024.01.22.576576.
Activity-Based Acylome Profiling with N-(Cyanomethyl)-N-(phenylsulfonyl)amides for Targeted Lysine Acylation and Post-Translational Control of Protein Function in Cells
Ryan, E. M., Norinskiy, M. A., Bracken, A. K., Lueders, E. E., Chen, X., Fu, Q., Anderson, E. T.,
Zhang, S., Abbasov, M. E.*
J. Am. Chem. Soc. 2024, 146, 40, 27622-27643.
Biomimetic synthesis and chemical proteomics reveal the mechanism of action and functional targets of phloroglucinol meroterpenoids
Bracken, A. K., Gekko, C. E., Suss, N. O., Lueders, E. E., Cui, Q., Fu, Q., Anderson, E. T., Zhang, S., Abbasov, M. E.*
J. Am. Chem. Soc. 2024, 146, 4, 2524–2548.
2021
A proteome-wide atlas of lysine-reactive chemistry
Abbasov, M. E., Kavanagh, M., Ichu, T.-A., Lazear, M. R., Tao, Y., Crowley, V. M., am Ende, C. W., Hacker, S. M., Ho, J., Dix, M. M., Suciu, R., Hayward, M. M., Kiessling, L. L., Cravatt, B. F.
Nat. Chem. 2021, 13, 1081–1092.
2020
ENANTIOSELECTIVE, ORGANOCATALYTIC STRATEGY FOR THE OXAZOLOMYCIN CORE: FORMAL SYNTHESIS OF (+)- NEOOXAZOLOMYCIN
Chaheine, C. M., Gladen, P. T., Abbasov, M. E., Romo, D.
Org. Lett. 2020, 22, 9282–9286.
2019
Simplified immunosuppressive and neuroprotective agents based on gracilin A
Abbasov, M. E., Alvariño, R.; Chaheine, C. M.; Alonso, E.; Sánchez, J. A.; Conner, M. L.; Alfonso, A.; Jaspars, M.; Botana, L. M.; Romo, D.
Nat. Chem. 2019, 11, 342–350.
Gracilin A derivatives target early events in Alzheimer’s disease: effects on neuroinflammation and oxidative stress
Alvariño, R., Alonso, E., Abbasov, M. E., Chaheine, C. M., Conner, M. L., Romo, D., Alfonso, A., Botana, L. M.
ACS Chem. Neurosci. 2019, 10, 4102–4111.
2017
Enantioselective Diels-Alder-lactamization organocascades employing a furan-based diene
Abbasov, M. E., Hudson, B. M., Tantillo, D. J., Romo, D.
Org. Biomol. Chem. 2017, 15, 3179–3183.
Stereodivergent, Diels-Alder-initiated organocascades employing α,β -unsaturated acylammonium salts: scope, mechanism, and application
Abbasov, M. E., Hudson, B. M., Tantillo, D. J., Romo, D.
Chem. Sci. 2017, 8, 1511–1524.
2014
Acylammonium salts as dienophiles in Diels-Alder/lactonization organocascades
Abbasov, M. E., Hudson, B. M., Tantillo, D. J., Romo, D.
J. Am. Chem. Soc. 2014, 136, 4492–4495.
The ever-expanding role of asymmetric covalent organocatalysis in scalable, natural product synthesis
Abbasov, M. E., Romo, D.
Nat. Prod. Rep. 2014, 31, 1318–1327.
2012
Effects of carbon nanotubes on electro-optical properties of dye-doped nematic liquid crystal
Abbasov, M. E., Carlisle, G. O.
J. Mater. Sci.: Mater. Electron. 2012, 23, 712–717.
2010
Hybrid carbon nanotube and dye-doped liquid crystal material for holographic imaging
Abbasov, M. E., Ghosh, S., Quach, A., Carlisle, G. O.
J. Mater. Sci.: Mater. Electron. 2010, 21, 854–859.
2008
Electric-field enhancement and modulation of permanent grating diffraction in dye and carbon nanotube-doped liquid crystal
Abbasov, M. E., Carlisle, G. O.
J. Nanophoton. 2008, 2, 023510.
Optical properties of permanent gratings in liquid crystal doped with dye and carbon nanotube
Suleiman, Y. S., Ghosh, S., Abbasov, M. E., Carlisle, G. O.
J. Mater. Sci.: Mater. Electron. 2008, 19, 662–668.
2024
CHEMICAL ACYLATING AGENTS AND CHEMOPROTEOMIC METHODS FOR POSTTRANSLATIONAL MODULATION OF PROTEIN FUNCTION IN LIVE CELLS
Ryan, E. M., Norinskiy, M. A., Abbasov, M. E.
Provisional patent application filed on May 3, 2024. Docket No. 11135-01-US.
2023
PHLOROGLUCINOL MEROTERPENOIDS AS LYSINE-TARGETING CHEMICAL PROBES FOR MODULATING MITOPHAGY AND DEGRADING BRCA1-MUTANT ONCOPROTEIN
Bracken, A. K., Gekko, C. E., Abbasov, M. E.
Provisional patent application filed on September 27, 2023. Docket No. 10898-01-US. App. No. 63/540, 783.
2018
Gracilin A and congeners as immunosuppressive and neuroprotective agents
Abbasov, M. E., Alvariño, R., Alonso, E., Sánchez, J. A., Alfonso, A., Botana, L. M., Romo, D.
U.S. Application No. 62/638,856 (WO/2019/173382). March 5, 2018.